A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

NCT01492647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: JNJ 10229570-AAA 1.2%
DRUG: JNJ 10229570-AAA 3.6%
DRUG: Color-matched vehicle containing 0 mg of JNJ 10229570-AAA

Sponsor

Janssen Pharmaceutical K.K.